Preview
Unable to display preview. Download preview PDF.
References
Abe T, Koyano K, Saisu H, Nishiuchi Y, Sakakibara S (1986) Binding of ω-conotoxin to receptor sites associated with the voltage-sensitive calcium channel. Neurosci Lett 71:203–208
Adams HR, Durrett LR (1978) Gentamicin blockade of slow Ca++ channels in atrial myocardium of guinea pigs. J Clin Invest 62:241–247
Affolter H, Coronado R (1986) Sidedness of reconstituted calcium channels from muscle tranverse tubules as determined by D600 and D890 blockade. Biophys J 49:767–772
Ahmad SN, Miljanich GP (1988) The calcium channel antagonist, ω-conotoxin and electric organ nerve terminals: binding and inhibition of transmitter release and calcium influx. Brain Res 453:247–256
Albus W, Habermann E, Ferry DR, Glossmann H (1984) Novel 1,4-dihydropyridine (Bay K8644) facilitates Ca-dependent [3H]noradrenaline release from PC12 cells. J Neurochem 42:1186–1189
Almers W, McCleskey EW, Palade PT (1984) A non-selective cation conductance in frog muscle membrane blocked by micromolar external calcium ions. J Physiol (Lond) 353:565–583
Balwierczak JL, Grupp IL, Grupp G, Schwartz A (1986) Effects of bepridil and diltiazem on [3H]intrendipine binding to canine cardiac sarcolemma. Potentiation of pharmacological effects of nitrendipine by bepridil. J Pharmacol Exp Ther 237:40–48
Barnes S, Davies JA (1988) The effect of calcium channel agonists and antagonists on the release of endogenous glutamate from cerebellar slices. Neurosci Lett 92:58–63
Beam KG, Knudson CM, Powell JA (1986) A lethal mutation in mice eliminates the slow calcium current in skeletal muscle cells. Nature 320:168–170
Bean BP (1984) Nitrendipine block of cardiac calcium channels: high affinity binding to the inactivated state. Proc Natl Acad Sci USA 81:6388–6392
Bean BP (1989) Classes of calcium channels in vertebrate cells. Ann Rev Physiol 51:367–384
Bean BP, Nowycky MC, Tsien RW (1984) β-Adrenergic modulation of calcium channels in frog ventricular heart cells. Nature 307:371–375
Bean BP (1985) Two kinds of calcium channels in canine atrial cells — differences in kinetics, selectivity and pharmacology. J Gen Physiol 86:1–30
Bechem M, Hebisch S, Schramm M (1988) Ca2+ agonists: new sensitive probes for Ca2+ channels. Trends Pharmacol Sci 9:257–261
Bellemann P (1984) Binding properties of a novel calcium channel activating dihydropyridine in monolayer cultures of beating myocytes. FEBS Lett 167:88–92
Bellemann P, Ferry D, Lübbecke F, Glossmann H (1981) [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes. Arzneimittelforschung 31:2064–2067
Bellemann P, Schade A, Towart R (1983) Dihydropyridine receptor in rat brain labeled with [3H]nimodipine. Proc Natl Acad Sci USA 80:2356–2360
Benos DJ (1982) Amiloride: a molecular probe of sodium transport in tissues and cells. Am J Physiol 242:C131–C145
Bergamaschi S, Govoni S, Cominetti P, Parenti M, Trabucchi M (1988) Direct coupling of a G-protein to dihydropyridine binding sites. Biochem Biophys Res Comm 156:1279–1286
Bixby JL, Spitzer NC (1983) Enkephalin reduces quantal content at frog neuromuscular junction. Nature 301:431–432
Bkaily G, Sperelakis N, Renaud JF, Payet MD (1985) Apamin, a highly specific Ca2+ blocking agent in heart muscle. Am J Physiol 248:H961–H965
Bodewei R, Hering S, Schubert B, Winkler J, Wollenberger A (1985) Calcium channel block by phenytoin in neuroblastoma-glioma hybrid cells. Biomed Biochim Acta 44:1229–1238
Bolger GT, Gengo PJ, Luchowski EM, Siegel H, Triggle DJ, Janis RA (1982) High affinity binding of a calcium channel antagonist to smooth and cardiac muscle. Biochem Biophys Res Commun 104:1604–1609
Bolger GT, Gengo P, Klockowski R, Luchowski E, Siegel H, Janis RA, Triggle AM, Triggle DJ (1983) Characterization of binding of the Ca++ channel antagonist [H-3]nitrendipine to guinea-pig ileal smooth muscle. J Pharmacol Exp Ther 225:291–309
Bolger GT, Marcus KA, Daly JW, Skolnick P (1987) Local anesthetics differentiate dihydropyridine calcium antagonist binding site in rat brain and cardiac membranes. J Pharmacol Exp Ther 240:922–930
Bosma M, Sidell N (1988) Retionic acid inhibits Ca2+ currents and cell proliferation in a B-lymphocyte cell line. J Cell Physiol 135:317–323
Brown AM, Kunze DL, Yatani A (1984) The agonist effect of dihydropyridines on Ca channels. Nature 311:570–572
Brown AM, Yatani A, Lacerda AE, Gurrola GB, Possani LD (1987) Neurotoxins that act selectively on voltage-dependent cardiac calcium channels. Cir Res 61 [Suppl I]:6–9
Brum G, Osterrieder W, Trautwein W (1984) β-Adrenergic increase in the calcium conductance of cardiac myocytes studied with the patch clamp. Pflüger Arch Eur J Physiol 401:111–118
Burges RA, Gardiner DG, Gwilt M, Higgins AJ, Blackburn KJ, Campbell SF, Cross PE, Stubbs JK (1987) Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors. J Cardiovasc Pharmacol 9:110–119
Cachelin AB, de Peyer JE, Kokubun S, Reuter H (1983) Ca2+ channel modulation by 8-bromocyclic AMP in cultured heart cells. Nature 304:462–464
Campbell KP, Leung AT, Sharp AH (1988) The biochemistry and molecular biology of the dihydropyridine-sensitive calcium channel. Trends Neurosci 11:425–430
Caparrotta L, Fassina G, Froldi G, Poja R (1987) Antagonism between (−)-N6-phenylisopropyl-adenosine and the calcium channel facilitator Bay K 8644, on guinea-pig isolated atria. Br J Pharmacol 90:23–30
Carbone E, Lux HD (1988) Sodium currents through neuronal calcium channels: kinetics and sensitivity to calcium antagonists. In: Morad M, Nayler W, Kazda S, Schramm M (eds) The calcium channel: structure, function and implications. Springer, Berlin Heidelberg New York, pp 115–127
Carbone E, Lux HD (1989) ω-Conotoxin blockade distinguishes Ca from Na permeable states in neuronal calcium channels. Pflügers Arch J Eur Physiol 413:14–22
Carbone E, Morad M, Lux HD (1987) External Ni2+ selectively blocks the low-threshold Ca2+ currents of chick sensory neurons. Pflügers Arch Europ J Physiol 408:R60 (abstract)
Casteels R, Login IS (1983) Reserpine has a direct action as a calcium antagonist on mammalian smooth muscle cells, J Physiol (Lond) 340:403–414
Catterall WA (1977) Activation of the action potential Na+ ionophore by neurotoxins. An allosteric model. J Biol Chem 252:8669–8676
Catterall WA (1981) Inhibition of voltage-sensitive sodium channels in neuroblastoma cells by antiarrhythmic drugs. Mol Pharmacol 20:356–362
Catterall WA (1987) Common modes of drug action on Na+ channels: local anesthetics antiarrhythmics and anticonvulsants. Trends Pharmacol Sci 8:57–65
Catterall WA (1988) Structure and function of voltage-sensitive ion channels. Science 242:50–61
Cavalié A, Ochi R, Pelzer D, Trautwein W (1983) Elementary currents through Ca2+ channels in guinea pig myocytes. Pflügers Arch Eur J Physiol 398:284–297
Ceña V, Nicolas GP, Sanchez-Garcia P, Kirpekar SM, Garcia AG (1983) Pharmacological dissection of receptor-associated and voltage-sensitive ionic channels involved in catecholamine release. Neuroscience 10:1455–1462
Chen C, Corbley MJ, Roberts TM, Hess P (1988) Voltage-sensitive calcium channels in normal and transformed 3T3 fibroblasts. Science 239:1024–1026
Chin PJS, Tetzloff G, Chatterjee M, Sybertz EJ (1988) Phorbol 12, 13-dibutyrate, an activator of protein kinase C, stimulates both contraction and Ca2+ fluxes in dog saphenous vein. Naunyn-Schmiedeberg's Arch Pharmacol 338:114–120
Cognard C, Romey G, Galizzi JP, Fosset M, Lazdunski M (1986) Dihydropyridine-sensitive Ca2+ channels in mammalian skeletal muscle cells in culture: electrophysiological properties and interactions with Ca2+ channel activator (Bay K 8644) and inhibitor (PN200-110). Proc Natl Acad Sci USA 83:1518–1522
Cohen CJ, McCarthy RT (1987) Nimodipine block of calcium channels in rat anterior pituitary cells. J Physiol (Lond) 387:195–225
Cohen CJ, McCarthy RT, Barrett PQ, Rasmussen H (1988) Ca channels in adrenal glomerulosa cells: K+ and angiotensin II increase T-type Ca channel current. Proc Natl Acad Sci USA 85:2412–2416
Contreras E, Tamayo L, Amigo M (1988) Calcium channel antagonists increase morphine-induced analgesia and antagonize morphine tolerance. Eur J Pharmacol 148:463–466
Cota G (1986) Calcium channel currents in pars intermedia cells of the rat pituitary gland. Kinetic properties and washout during intracellular dialysis. J Gen Physiol 88:83–105
Crosland RD, Hsiao TH, McClure WO (1984) Purification and characterization of β-leptinotarsin-n an activator of presynaptic calcium channels. Biochemistry 23:734–741
Cruz LJ, Olivera BM (1986) Calcium channel antagonist ω-conotoxin defines a new high affinity site. J Biol Chem 261:6230–6233
Cruz LJ, Johnson DS, Olivera BM (1987) Characterization of the ω-conotoxin target. Evidence for tissue-specific heterogeneity in calcium channel types. Biochemistry 26:820–824
Deisz RA, Lux HD (1985) γ-Aminobutyric acid-induced depression of calcium currents of chick sensory neurons. Neurosci Lett 56:205–210
Delorme EM, McGee R (1986) Regulation of voltage-dependent Ca2+ channels of neuronal cells by chronic changes in membrane potentials. Brain Res 397:189–192
Delorme EM, Rabe CS, McGee R (1988) Regulation of the number of functional voltage-sensitive Ca++ channels on PC 12 cells by chronic changes in membrane potential. J Pharmacol Exp Ther 244:838–843
De Pover A, Grupp I, Grupp G, Schwartz A (1983) Diltiazem potentiates the negative inotropic action of nimodipine in the heart. Biochim Biophys Res Commun 114:922–929
DeRiemer SA (1989) Functions for calcium channels in pituitary cells. Ann NY Acad Sci 560:413–414
DeRiemer SA, Strong JA, Albert KA, Greengard P, Kaczmarek LK (1985) Enhancement of calcium current in aplysia neurones by phorbol ester and protein kinase C. Nature 313:313–316
Désarmenien M, Feltz P, Occhipinti G, Santangelo F, Schlichter R (1984) Coexistence of GABAA and GABAB receptors on Aδ and C primary afferents. Br J Pharmacol 81:327–333
Desnuelle C, Askanas V, Engel WK (1987) Insulin enhances development of functional voltagedependent Ca2+ channels in aneurally cultured human muscle. J Neurochem 49:1133–1139
DiVirgilio F, Pozzan T, Wollheim CB, Vicentini LM, Meldolesi J (1986) Tumor promoter phorbol myristate acetate inhibits Ca2+ influx through voltage-gated Ca2+ channels in two secretory cell lines, PC 12 and RINm5F. J Biol Chem 261:32–35
Docherty RJ (1988) Gadolinium selectively blocks a component of calcium current in rodent neuroblastoma glioma hybrid (NG 108-15) cells. J Physiol (Lond) 398:33–47
Dolphin AC, Scott RH (1986) Inhibition of calcium currents in cultured rat dorsal root ganglion neurones by (-)-baclofen. Br J Pharmacol 88:213–220
Dolphin AC, Scott RH (1987) Calcium channel currents and their inhibition by (-)-baclofen in rat sensory neurones: modulation by guanine nucleotides. J Physiol (Lond) 386:1–17
Dolphin AC, Forda SR, Scott RH (1986) Calcium-dependent currents in cultured rat dorsal root ganglion neurones are inhibited by an adenosine analogue. J Physiol (Lond) 373:47–61
Dooley DJ, Lupp A, Hertting G, Osswald H (1988) ω-Conotoxin GVIA and pharmacological modulation of hippocampal noradrenaline release. Eur J Pharmacol 148:261–268
Dubé GP, Baik YH, Schwartz A (1985a) Effects of a novel calcium channel agonist dihydropyridine analogue, Bay K 8644, on pig coronary artery: biphasic mechanical response and paradoxial potentiation of contraction by diltiazem and nimodipine. J Cardiovasc Pharmacol 7:377–389
Dubé GP, Baik YH, Vaghy PL, Schwartz A (1985b) Nitrendipine potentiates Bay K 8644-induced contraction of isolated porcine coronary artery: evidence for functionally distinct dihydropyridine receptor subtypes. Biochem Biophys Res Commun 128:1295–1302
Dunlap K (1981) Two types of γ-aminobutyric acid receptor on embryonic sensory neurons. Br J Pharmacol 74:579–585
Dunlap K, Fischbach GD (1981) Neurotransmitters decrease the calcium conductance activated by depolarization of embryonic chick sensory neurones. J Physiol (Lond) 317:519–535
Enyeart JJ, Aizawa T, Hinkle PM (1985) Dihydropyridine Ca2++ antagonists: potent inhibitors of secretion from normal and transformed pituitary cells. Am J Physiol 248:C510–C519
Enyeart JJ, Aizawa T, Hinkle PM (1986) Interaction of dihydropyridine Ca2+ agonist Bay-K 8644 with normal and transformed pituitary cells. Am J Physiol 250:C95–C103
Enyeart JJ, Sheu SS, Hinkle PM (1987) Pituitary Ca2+ channels: blockade by conventional and novel Ca2+ antagonists. Am J Physiol 253:C162–C170
Ewald DA, Matthies HJG, Perney TM, Walker MW, Miller RJ (1988a) The effect of down regulation of protein kinase C on the inhibitory modulation of dorsal root ganglion neuron Ca2+ currents by neuropeptide Y. J Neurosci 8:2447–2451
Ewald DA; Sternweis PC, Miller RJ (1988b) Guanine nucleotide-binding protein Go-induced coupling of neuropeptide Y receptors to Ca channels in sensory neurons. Proc Natl Acad Sci USA 85:3633–3637
Fish RD, Sperti G, Colucci WS, Clapham DE (1988) Phorbol ester increases the dihydropyridine-sensitive calcium conductance in a vascular smooth muscle cell line. Circ Res 62:1049–1054
Fitzpatrick LA, Brandi ML, Aurbach GD (1986) Control of PTH secretion is mediated through calcium channels and is blocked by pertussis toxin treatment of parathyroid cells. Biochem Biophys Res Commun 138:960–965
Fitzpatrick LA, Chin H, Nirenberg M, Aurbach GD (1988) Antibodies to an α-subunit of skeletal muscle calcium channels regulate parathyroid cell secretion. Proc Natl Acad Sci USA 85:2115–2119
Flaim SF, Brannan MD, Swigart SC, Gleason MM, Muschek LD (1985) Neuroleptic drugs alternate calcium influx and tension development in rabbat thoracic aorta: effects of pimozide, penfluridol, chlorpromazine and haloperidol. Proc Natl Acad Sci USA 82:1237–1241
Fleckenstein A (1977) Specific pharmacology of calcium in myocardium, cardiac pacemakers and vascular smooth muscle. Annu Rev Pharmacol Toxicol 17:149–166
Forder J, Scriabine A, Rasmussen H (1985) Plasma membrane calcium flux, protein kinase C activation and smooth muscle contraction. J Pharmacol Exp Ther 235:267–273
Forscher P, Oxford GS (1985) Modulation of calcium channels by norepinephrine in internally dialyzed avian sensory neurons. J Gen Physiol 85:743–763
Fosset M, Jaimovich E, Delpont E, Lazdunski M (1982) [3H]Nitrendipine labelling of the Ca2+-channel in skeletal muscle. Eur J Pharmacol 86:141–142
Fox AP, Nowycky MC, Tsien RW (1987a) Kinetic and pharmacological properties distinguishing three types of Ca currents in chick sensory neurons. J Physiol (Lond) 394:149–172
Fox AP, Nowycky MC, Tsien RW (1987b) Single channel recordings of three types of calcium channels in chick sensory neurones. J Physiol (Lond) 394:173–200
Franckowiak G, Bechem M, Schramm M, Thomas G (1985) The optical isomers of the 1,4-dihydropyridine Bay K 8644 show opposite effects on Ca channels. Eur J Pharmacol 114:223–226
Freedman SB, Miller RJ (1984) Calcium channel activation: a different type of drug action. Proc Natl Acad Sci USA 81:5580–5583
Galizzi JP, Fosset M, Lazdunski M (1984) Properties of receptors for the Ca2+-channel blocker verapamil in transverse-tubule membranes of skeletal muscle. Stereospecifity, effect of Ca2+ and other inorganic cations, evidence for two categories of sites and effect of nucleoside triphosphate. Eur J Biochem 144:211–214
Galizzi JP, Fosset M, Lazdunski M (1985) Characterization of the Ca2+ coordination site regulating binding of Ca2+ channel inhibitors d-cis-diltiazem (±) bepridil and (−) desmethoxyverapamil to their receptor site in skeletal muscle transverse tubule membranes. Biochem Biophys Res Commun 132:49–55
Galizzi JP, Borsotto M, Barhanin J, Fosset M, Lazdunski M (1986a) Characterization and photoaffinity labelling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (±)-bepridil, desmethoxyverapamil and (+)-PN 200-110 in skeletal muscle transverse tubule membranes. J Biol Chem 261:1393–1397
Galizzi JP, Fosset M, Romey G, Laduron P, Lazdunski M (1986b) Neuroleptics of the diphenylbutylpiperidine series are potent Ca channel inhibitors. Proc Natl Acad Sci USA 83:7513–7517
Galizzi JP, Qar J, Fosset M, van Renterghem C, Lazdunski M (1987) Regulation of calcium channels in aortic muscle cells by protein kinase C activators (diacylglycerol and phorbol esters) and by peptides (vasopressin and bombesin) that stimulate phosphoinositide breakdown. J Biol Chem 262:6947–6950
Galvan M, Adams PR (1982) Control of calcium current in rat sympathetic neurons by norepinephrine. Brain Res 244:135–144
Garcia AG, Sala F, Reig JA, Viniegra S, Frias J, Fontériz R, Gandia L (1984) Dihydropyridine Bay-K-8644 activates chromaffin cell calcium channels. Nature 309:69–71
Garcia ML, King VF, Siegl PKS, Reuben JP, Kaczorowski GJ (1986) Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane viscles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors. J Biol Chem 261:8146–8157
Gershengorn MC, Thaw CN, Raaka EG (1988) Benzodiazepines modulate voltage-sensitive calcium channels in GH3 pituitary cells at sites distinct from thyrotropin-releasing hormone receptors. Endocrinology 123:541–544
Gjörstrup P, Hardin H, Isaksson R, Westerlund C (1986) The enantiomers of the dihydropyridine derivative H160/51 show opposite effects of stimulation and inhibition. Eur J Pharmacol 122:357–361
Glossmann H, Striessnig J (1988) Calcium channels. Vitam Horm 44:155–328
Glossmann H, Striessnig J (1989) Molecular properties of calcium channels. Rev Physiol Biochem Pharmacol (this volume)
Glossmann H, Ferry DR, Lübbecke F, Mewes R, Hofmann F (1982) Calcium channels: direct identification with radioligand binding studies. Trends Pharmacol Sci 3:431–437
Glossmann H, Ferry DR, Goll A, Striessnig J, Zernig G (1985a) Calcium channels and calcium channel drugs — recent biochemical and biophysical findings. Arzneimittelforschung 35-2:1917–1935
Glossmann H, Ferry DR, Goll A, Striessnig J, Schober M (1985b) Calcium channels: basic properties as revealed by radioligand binding studies. J Cardiovasc Pharmacol 7 [Suppl 6]:S20–S30
Godfraind T, Miller R, Wibo M (1986) Calcium antagonists and calcium entry blockade. Pharmacol Rev 38:321–416
Goll A, Glossmann H, Mannhold R (1986) Correlation between the negative inotropic potency and binding parameters of 1,4-dihydropyridine and phenylalkylamine calcium channel blockers in cat heart. Naunyn-Schmiedeberg's Arch Pharmacol 334:303–312
Gould RJ, Murphy KMM, Reynolds IJ, Snyder SH (1983) Antischizophrenic drugs of the diphenylbutylpiperidine type act as Ca channel antagonists. Proc Natl Acad Sci USA 80:5122–5125
Gray WR, Olivera BM, Cruz LJ (1988) Peptide toxins from venomous conus snails. Annu Rev Biochem 57:665–700
Green FJ, Farmer BB, Wiseman GL, Jose MJL, Watanabe AM (1985) Effect of membrane depolarization on binding of [3H]nitrendipine to rat cardiac myocytes. Circ Res 56:576–585
Greenberg DA, Carpenter CL, Messing RO (1986) Depolarization-dependent binding of the calcium channel antagonist (+)-[H-3] PN 200-110 to intact cultured PC 12 cells. J Pharmacol Exp Ther 328:1021–1027
Greenberg DA, Carpenter CL, Messing RO (1987) Lectin-induced enhancement of volt-age-dependent calcium flux and calcium channel antagonist binding. J Neurochem 48:888–894
Gross RA, Macdonald RL (1987) Dynorphin A selectively reduces a large transient (N-type) calcium current of mouse dorsal root ganglion neurons in cell culture. Proc Natl Acad Sci USA 84:5469–5473
Gurney AM, Nerbonne JM, Lester HA (1985) Photoinduced removal of nifedipine reveals mechanisms of calcium antagonist action on single heart cells. J Gen Physiol 86:353–380
Hadley RW, Hume JR (1988) Calcium channel antagonist properties of Bay K 8644 in single guinea pig ventricular cells. Circ Res 62:97–104
Hagiwara N, Irisawa H, Kameyama M (1988) Contributions of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol (Lond) 395:233–253
Hamilton SL, Perez M (1987) Toxins that affect voltage-dependent calcium channels. Biochem Pharmacol 36:3325–3330
Hamilton SL, Yatani A, Hawkes MJ, Redding K, Brown AM (1985) Atrotoxin: a specific agonist for calcium currents in the heart. Science 229:182–185
Hamilton SL, Yatani A, Brush K, Schwartz A, Brown AM (1987) A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes. Mol Pharmacol 31:221–230
Harris RA, Jones SB, Bruno P, Bylund DB (1985) Effects of dihydropyridine derivatives and anticonvulsant drugs on [3H]nitrendipine binding and calcium and sodium fluxes in brain. Biochem Pharmacol 34:2187–2191
Hawthorn MH, Gengo P, Wei XY, Rutledge A, Moran JF, Gallant S, Triggle DJ (1988) Effect of thyroid status on β-adrenoceptors and calcium channels in rat cardiac and vascular tissues. Naunyn-Schmiedeberg's Arch Pharmacol 337:539–544
Hay DWP, Wadsworth RM (1982) Local anaesthetic activity of organic calcium antagonists: relevance to their actions on smooth muscle. Eur J Pharmacol 77:221–228
Herbette LG, Katz AM (1987) Molecular model for the binding of 1,4-dihydropyridine calcium channel antagonists to their receptor in the heart: drug “imaging” in membranes and consideration for drug design. In: Venter JC, Triggle D (eds) Structure and physiology of the slow inward calcium channel. Liss, New York, pp 89–108 (Receptor Biochemistry and Methodology, vol 9)
Hescheler J, Pelzer D, Trube G, Trautwein W (1982) Does the organic calcium channel blocker D 600 act from inside or outside on the cardiac cell membrane? Pflügers Arch Eur J Physiol 393:287–291
Hescheler J, Rosenthal W, Trautwein W, Schultz G (1987) The GTP-binding protein, Go, regulates neuronal calcium channels. Nature 325:445–447
Hescheler J, Rosenthal W, Hinsch KD, Wulfern M, Trautwein W, Schultz G (1988) Angiotensin II-induced stimulation of voltage-dependent Ca2+ currents in an adrenal cortical cell line. EMBO J 7:619–624
Hess P, Tsien RW (1984) Mechanism of ion permeation through calcium channels. Nature 309:453–456
Hess P, Lansman JB, Tsien RW (1984) Different modes of channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists. Nature 311:538–544
Higo K, Saito H, Matsuki N (1988) Characteristics of [3H]nimodipine binding to sarcolemmal membranes from rat vas deferens and its regulation by guanine nucleotide. Jpn J Pharmacol 48:213–222
Hille B (1977) Local anesthetics: hydrophilic and hydrophobic pathways for the drug receptor reaction. J Gen Physiol 69:497–515
Hille B (1984) Ionic channels of excitable membranes. Sinauer, Sunderland MA, pp 316–320
Hirning LD, Fox AP, McCleskey EW, Olivera BM, Thayer SA, Miller RJ, Tsien TW (1988) Dominant role of N-type Ca2+ channels in evoked release of norephinephrine from sympathic neurons. Science 239:57–61
Hof RP, Rüegg UT, Hof A, Vogel A (1985) Stereoselectivity at the calcium channel: opposite action of the enantiomers of a 1,4-dihydropyridine. J Cardiovasc Pharmacol 7:689–693
Hof RP, Hof A, Rüegg UT, Cook NS, Vogel A (1986) Stereoselectivity at the calcium channel: different profiles of hemodynamic activity of the enantiomers of the dihydropyridine derivative PN 200-110. J Cardiovasc Pharmacol 8:221–226
Holck M, Osterrieder W (1985) The peripheral high affinity benzodiazepine binding site is not coupled to the cardiac Ca2+ channel. Eur J Pharmacol 118:293–301
Höltje HD, Marrer S (1987) A molecular graphics study on structure-action relationships of calcium-antagonistic and agonistic 1,4-dihydropyridines. J Comp aided Mol Des 1:23–30
Holz GG, Rane SG, Dunlap K (1986) GTP-binding proteins mediate transmitter inhibition of voltage-dependent calcium channels. Nature 319:670–672
Holz GG, Kream RM, Spiegel A, Dunlap K (1989) G-proteins couple α-adrenergic and GABAb receptors to inhibition of peptide secretion from peripheral sensory neurons. J Neurosci 9:657–666
Hondeghem LM, Katzung BG (1977) Time and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochem Biophys Acta 472:373–398
Hondeghem LM, Katzung BG (1984) Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. Annu Rev Pharmacol Toxicol 24:387–423
Hosey MM, Lazdunski M (1988) Calcium channels: molecular pharmacology, structure and regulation. J Membr Biol 104:81–106
Janis RA, Triggle DJ (1984) 1,4-Dihydropyridine Ca2+ channel antagonists and activators: a comparison of binding characteristics with pharmacology. Drug Dev Res 4:257–274
Janis RA, Sarmiento JG, Maurer SC, Bolger GT, Triggle DJ (1984a) Characteristics of the binding of [H-3]nitrendipine to rabbit ventricular membranes — modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K-8644. J Pharmacol Exp Ther 231:8–15
Janis RA, Rampe D, Sarmiento JG, Triggle DJ (1984b) Specific binding of a calcium channel activator [3H] Bay K 8644 to membranes from cardiac muscle and brain. Biochem Biophys Res Commun 121:317–323
Janis RA, Silver PJ, Triggle DJ (1987) Drug action and cellular calcium regulation. Adv Drug Res 16:309–589
Johansen J, Taft WC, Yang J, Kleinhans AL, de Lorenzo RJ (1985) Inhibition of Ca2+ conductance in identified leech neurons by benzodiazepines. Proc Natl Acad Sci USA 82:3935–3939
Kaczmarek LK (1987) The role of protein kinase C in the regulation of ion channels and neurotransmitter release. Trends Neurosci 10:30–34
Kanaya S, Arlock P, Katzung BG, Hondeghem LM (1983) Diltiazem and verapamil preferentially block inactivated cardiac calcium channels. J Mol Cell Cardiol 15:145–148
Kass RS (1987) Voltage-dependent modulation of cardiac calcium channel current by optical isomers of Bay K 8644: implications for channel gating. Circ Res 61 [Suppl 1]:1–5
Kass RS, Arena JP (1989) Influence of pH0 on calcium channel block by amlodipine, a charged dihydropyridine compound. Implications for location of the dihydropyridine receptor. J Gen Physiol 93:1109–1127
Kass RS, Krafte DS (1987) Negative surface charge density near heart calcium channels. Relevance to block by dihydropyridines. J Gen Physiol 89:629–644
Kass RS, Arena JP, DiManno D (1988) Block of heart calcium channels by amlodipine: Influence of drug charge on blocking activity. J Cardiovasc Pharmacol 12 (Suppl 7):S45–S49
Kawashima Y, Ochi R (1988) Voltage-dependent decrease in the availability of single calcium channels by nitrendipine in guinea-pig ventricular cells. J Physiol (Lond) 402:219–235
Kerr LM, Yoshikami D (1984) A venom peptide with a novel presynaptic blocking action. Nature 308:282–284
King VF, Garcia ML, Himmel D, Reuben JP, Lam YKT, Pan JX, Han GQ, Kaczorowski GJ (1988) Interaction of tetrandrine with slowly inactivating calcium channels. Characterization of Ca channel modulation by an alkaloid of Chinese medical herb origin. J Biol Chem 263:2238–2244
Knaus HG, Striessnig J, Koza A, Glossmann H (1987) Neurotoxic aminoglycoside antibiotics are potent inhibitors of [125I]-omega-conotoxin GVIA binding to guinea-pig cerebral cortex membranes. Naunyn-Schmiedeberg's Arch Pharmacol 336:583–586
Kobayashi M, Ohizumi Y, Yasumoto T (1985) The mechanism of action of maitotoxin in relation to Ca2+ movements in guinea-pig and rat cardiac muscles. Br J Pharmacol 86:385–391
Kobayashi M, Kondo S, Yasumoto T, Ohizumi Y (1986) Cardiotoxic effects of maitotoxin, a principal toxin of seafood poisoning, on guinea pig and rat cardiac muscle. J Pharmacol Exp Ther 238:1077–1083
Kojima I, Shibata H, Ogata E (1986) Pertussis toxin blocks angiotensin II-induced calcium influx but not inositol triphosphate production in adrenal glomerulosa cell. FEBS Lett 204:347–351
Kokubun S, Reuter H (1984) Dihydropyridine derivatives prolong the open state of Ca channels in cultured cardiac cells. Proc Natl Acad Sci USA 81:4824–4827
Kokubun S, Prod'hom B, Porzig H, Reuter H (1986) Studies on Ca channels in intact cardiac cells: voltage-dependent effects and cooperative interactions of dihydropyridine enantiomers. Mol Pharmacol 30:571–584
Kongsamut S, Miller RJ (1986) Nerve growth factor modulates the drug sensitivity of neurotransmitter release from PC 12 cells. Proc Natl Acad Sci USA 83:2243–2247
Kongsamut S, Kamp TJ, Miller RJ, Sanguinetti MC (1985a) Calcium channel agonist and antagonist effects of the steroisomers of the dihydropyridine 202–791. Biochem Biophys Res Commun 130:141–148
Kongsamut S, Freedman SB, Simon BE, Miller RJ (1985b) Interaction of steroidal alkaloid toxins with Ca channels in neuronal cell lines. Life Sci 36:1493–1501
Kostyuk PG, Mironov SL, Shuba YM (1983) Two ion-selecting filters in the calcium channel of the somatic membrane of mollusc neurons. J Membr Biol 76:83–93
Kunze DL, Hamilton SL, Hawkes MJ, Brown AM (1987) Dihydropyridine binding and calcium channel function in clonal rat adrenal medullary tumor cells. Mol Pharmacol 31:401–409
Lacerda AE, Brown AM (1986) Atrotoxin increases probability of opening of single Ca channels in cultured rat ventricular cells. Biophys J 49:174a
Lamb GD, Walsh T (1987) Calcium currents, charge movement and dihydropyridine binding in fast-and slow-twitch muscles of rat and rabbit. J Physiol (Lond) 393:595–617
Laurent S, Kim D, Smith TW, Marsh JD (1985) Inotropic effect, binding properties and calcium flux effects of the calcium agonist CGP 28392 in intact cultured embryonic chick ventricular cells. Circ Res 56:676–682
Lazdunski M, Frelin C, Vigne P (1985) The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol 17:1029–1042
Lee KS, Tsien RW (1983) Mechanism of calcium channel blockade by verapamil, D 600, diltiazem and nitrendipine in single dialysed heart cells. Nature 302:790–794
Lee RT, Smith TW, Marsh JD (1987) Evidence for distinct calcium channel agonist and antagonist binding sites in intact cultured embryonic chick ventricular cells. Circ Res 60:683–691
Levitan IB (1988) Modulation of ion channels in neurons and other cells. Annu Rev Neurosci 11:119–136
Lewis DL, Weight FF, Luini A (1986) A guanine nucleotide-binding protein mediates the inhibition of voltage-dependent calcium current by somatostatin in a pituitary cell line. Proc Natl Acad Sci USA 83:9035–9039
Lipscombe D, Tsien RW (1987) Noradenaline inhibits N-type Ca channels in isolated frog sympathetic neurons. J Physiol (Lond) 390:84P
Lipscombe D, Madison DV, Poenie M, Reuter H, Tsien RY, Tsien RW (1988) Spatial distribution of calcium channels and cytosolic calcium transients in growth cones and cell bodies of sympathetic neurons. Proc Natl Acad Sci USA 85:2398–2402
Ljung B, Kjellstedt A, Orebäck B (1987) Vascular versus myocardial selectivity of calcium antagonists studied by concentration-time-effect relations. J Cardiovasc Pharmacol 10[Suppl 1]:S34–S39
Login IS, Judd AM, Cronin MJ, Yasumoto T, Macleod RM (1985) Reserpine is a calcium channel antagonist in normal and GH3 rat pituitary cells. Am J Physiol 248:E15–E19
Lorentz M, Hedlung B, Århem P (1988) Morphine activates calcium channels in cloned mouse neuroblastoma cell lines. Brain Res 445:157–159
Loutzenhiser R, Rüegg U, Hof RP (1984) Studies on the mechanism of action of the vasoconstrictive dihydropyridine CGP 28392. Eur J Pharmacol 105:229–237
Lüllmann H, Mohr K (1987) High and concentration-proportional accumulation of [3H]-nitrendipine by intact cardiac tissue. Br J Pharmacol 90:567–574
Maan AC, Hosey MM (1987) Analysis of the properties of binding of calcium-channel activators and inhibitors to dihydropyridine receptors in chick heart membranes. Circ Res 61:379–388
Madison DV, Fox AP, Tsien RW (1987) Adenosine reduces an inactivating component of calcium current in hippocampal CA3 neurons. Biophys J 51:30a (abstract)
Maggi CA, Patacchini R, Santicioli P, Lippe IT, Guiliani S, Geppetti P, Del Bianco E, Selleri S, Meli A (1988) The effect on omega conotoxin GVIA, a peptide modulator of the N-type voltage sensitive calcium channels, on motor responses produced by activation of efferent and sensory nerves in mammalian smooth muscle. Naunyn-Schmiedeberg's Arch Pharmacol 338:107–113
Mannhold R, Rodenkirchen R, Bayer R, Haas W (1984) The importance of drug ionization for the action of calcium antagonists and related compounds. Arzneimittelforschung 34:407–410
Marchetti C, Brown AM (1988) Protein kinase activator 1-oleoyl-2-acetyl-sn-glycerol inhibits two types of calcium current in GH3 cells. Am J Physiol 254:C206–C210
Marchetti C, Carbone E, Lux HD (1986) Effects of dopamine and noradrenaline on Ca channels of cultured sensory and sympathetic neurons of chick. Pflügers Arch Eur J Physiol 406:104–111
Martin-Moutot N, Marqueze B, Azais F, Seagar M, Couraud F (1989) Properties of the calcium channel associated ω-conotoxin receptor in rat brain. Ann NY Acad Sci 560:53–55
Masuda MO, de Magalhães-Engel G, Barbose Moreira AP (1987) Characterization of isolated ventricular myocytes: two levels of resting potential. J Mol Cell Cardiol 19:831–840
Matteson DR, Armstrong CM (1986) Properties of two types of calcium channels in clonal pituitary cells. J Gen Physiol 87:161–182
McCleskey EW, Almers W (1985) The Ca channel is a large pore. Proc Natl Acad Sci USA 82:7149–7153
McCleskey EW, Fox AP, Feldman DH, Cruz LJ, Olivera BM, Tsien RW, Yoshikami D (1987) ω-Conotoxin: direct and persistent blockade of specific types of calcium channels in neurons but not muscle. Proc Natl Acad Sci USA 84:4327–4331
Messing RO, Carpenter CL, Greenberg DA (1985) Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists. J Pharmacol Exp Ther 235:407–411
Messing RO, Carpenter CL, Greenberg DA (1986a) Inhibition of calcium flux and calcium channel antagonist binding in the PC 12 cell line by phorbol esters and protein kinase C. Biochem Biophys Res Commun 136:1049–1056
Messing RO, Carpenter CL, Diamond I, Greenberg DA (1986b) Ethanol regulates calcium channels in clonal neural cells. Proc Natl Acad Sci USA 83:6213–6215
Mestre M, Carriot T, Néliat G, Uzan A, Renault C, Dubroeucq MC, Guérémy C, Doble A, LeFur G (1986a) PK 11195 an antagonist of peripheral type benzodiazepine receptors modulates Bay K 8644 sensitive but not β-or H2-receptor sensitive voltage-operated calcium channels in the guinea pig heart. Life Sci 39:329–340
Mestre M, Belin C, Uzan A, Renault C, Dubroeucq MC, Gueremy C, LeFur G (1986b) Modulation of voltage-operated, but not receptor-operated, calcium channels in the rabbit aorta by PK 11195, an antagonist of peripheral type benzodiazepine receptors. J Cardiovasc Pharmacol 8:729–734
Miller RJ (1987a) Multiple calcium channels and neuronal function. Science 235:46–52
Miller RJ (1987b) Calcium channels in neurons. In: Venter JC, Triggle D (eds) Structure and physiology of the slow inward calcium channel. Liss, New York, pp 161–246 (Receptor biochemistry and methodology, vol 9)
Miller RJ, Freedman SB (1984) Are dihydropyridine binding sites voltage-sensitive calcium channels? Life Sci 34:1205–1222
Mir AK, Spedding M (1987) Calcium antagonist properties of diclofurime isomers. II. Molecular aspects: allosteric interactions with dihydropyridine recognition sites. J Cardiovasc Pharmacol 9:469–477
Monod J, Wyman J Changeux JP (1965) On the nature of allosteric transitions: a plausible model. J Mol Biol 12:88–118
Morel N, Godfraind T (1987) Prolonged depolarization increases the pharmacological effect of dihydropyridines and their binding affinity for calcium channels of vascular smooth muscle. J Pharmacol Exp Ther 243:711–715
Motomura S, Hashimoto K, Hashimoto K (1987) Effects of Bay K 8644 on the coronary vascular selectivity of the dihydropyridine Ca antagonists in the canine isolated blood-perfused papillary muscle preparation. J Cardiovasc Pharmacol 10:627–635
Mudge AW, Leeman SE, Fischbach GD (1979) Enkephalin inhibits release of substance P from sensory neurons in culture and decreases action potential duration. Proc Natl Acad Sci USA 76:526–530
Murphy KMM, Snyder SH (1982) Calcium antagonist receptor binding sites labeled with [3H]nitrendipine. Eur J Pharmacol 77:201–202
Narahashi T (1988) Drugs acting on calcium channels. In: Baker PF (ed) Calcium in drug actions. Springer, Berlin Heidelberg New York, pp 255–274 (Handbuch der experimentellen Pharmakologie, vol 83)
Navarro J (1987) Modulation of [3H]dihydropyridine receptors by activation of protein kinase C in chick muscle cells. J Biol Chem 262:4649–4652
Nelson MT, Standen NB, Brayden JE, Worley JF (1988) Noradrenaline contracts arteries by activating voltage-dependent calcium channels. Nature 336:382–385
Nishiyama T, Kobayashi A, Haga T, Yamazaki N (1986) Chronic treatment with nifedipine does not change the number of [3H]dihydroalprenolol binding sites. Eur J Pharmacol 121:167–172
North RA (1986) Opioid receptor types and membrane ion channels. Trends Neurosci 9:114–117
Olivera BM, Gray WR, Zeikus R, McIntosh JM, Varga J, Rivier J, de Santos V, Cruz LJ (1985) Peptide neurotoxins from fish-hunting conesnails. Science 230:1338–1343
Osugi T, Imaizumi T, Mizushima A, Uchida S, Yoshida H (1986) 1-Oleoyl-2-acetyl-glycerol and phorbol diester stimulate Ca2+ influx through Ca2+ channels in neuroblastoma x glioma hybrid NG 108-15 cells. Eur J Pharmacol 126:47–52
Oyama Y, Tsuda Y, Sakakibara S, Akaike N (1987) Synthetic ω-conotoxin: a potent calcium channel blocking neurotoxin. Brain Res 424:58–64
Peres A, Sturani E, Zippel R (1988) Properties of the voltage-dependent calcium channel of mouse Swiss 3T3 fibroblasts. J Physiol (Lond) 401:639–656
Perney TM, Hirning LD, Leeman SE, Miller RJ (1986) Multiple calcium channels mediate neurotransmitter release from peripheral neurons. Proc Natl Acad Sci USA 83:6656–6659
Pietrobon D, Prod'hom B, Hess P (1988) Conformational changes associated with ion permeation in L-type calcium channels. Nature 333:373–376
Plummer MR, Logothetis DE, Hess P (1989) Elementary properties and pharmacological sensitivities of calcium channels in mammalian peripheral neurons. Neuron 2:1453–1463
Porzig H, Becker C (1988) Potential-dependent allosteric modulation of 1,4-dihydropyridine binding by d-(cis)-diltiazem and (±)-verapmil in living cardiac cells. Mol Pharmacol 34:172–179
Porzig H, Becker C, Reuter H (1989) Effects of NGF-induced differentiation on two classes of Ca channels in living PC 12 cells. Experientia 45:A28 (abstract)
Postma SW, Catterall WA (1984) Inhibition of binding of [3H]batrachotoxin Δ20-α-benzoate to sodium channels by local anaesthetics. Mol Pharmacol 25:219–227
Powers RE, Colucci WS (1985) An increase in putative voltage-dependent calcium channel number following reserpine treatment. Biochem Biophys Res Commun 132:844–849
Qar J, Schweitz H, Schmid A, Lazdunski M (1986) A polypeptide toxin from the coral Goniopora. Purification and action on Ca2+ channels. FEBS Lett 202:331–336
Qar J, Galizzi JP, Fosset M, Lazdunski M (1987) Receptors for diphenylbutylpiperidine neuroleptics in brain, cardiac and smooth muscle membranes. Relationship with receptors for 1,4-dihydropyridines and phenylalkylamines and with Ca2+ channel blockade. Eur J Pharmacol 141:261–268
Ramkumar V, El-Fakahany EE (1984) Increase in [3H]nitrendipine binding sites in the brain in morphine-tolerant mice. Eur J Pharmacol 102:371–373
Ramkumar V, El-Fakahany EE (1985) Changes in the affinity of [3H]nimodipine binding sites in the brain upon chlorpromazine treatment and subsequent withdrawal. Res Commun Chem Pathol Pharmacol 48:463–466
Rampe D, Triggle DJ (1986) Benzodiazepines and calcium channel function. Trends Pharmacol Sci 7:461–464
Rane SG, Dunlap K (1986) Kinase C activator 1,2-oleoyl acetylglycerol attenuates voltage-dependent calcium current in sensory neurones. Proc Natl Acad Sci USA 83:184–188
Rane SG, Holz GG, Dunlap K (1987) Dihydropyridine inhibition of neuronal calcium current and substance P release. Pflügers Arch Eur J Physiol 409:361–366
Rane SG, Holz GG, Anderson CS, Dunlap K (1989) Calcium channel modulation via G-proteins and protein kinase C. 4th Int. Symp. Calcium Antagonists, Florence May 1989 (abstracts p 5–7)
Renaud JF, Kazazoglou T, Schmid A, Romey G, Lazdunski M (1984) Differentiation of receptor sites for [3H]nitrendipine in chick hearts and physiological relation to slow Ca2+ channel and to excitation contraction coupling. Eur J Biochem 139:673–681
Reuter H (1983) Calcium channel modulation by neurotransmitters, enzymes and drugs. Nature 301:569–574
Reuter H (1984) Ion channels in cardiac cell membranes. Annu Rev Physiol 46:473–484
Reuter H (1987) Modulation of ion channels by phosphorylation and second messengers. News Physiol Sci 2:168–171
Reuter H, Stevens CF, Tsien RW, Yellen G (1982) Properties of single calcium channels in cardiac cell culture. Nature 297:501–504
Reuter H, Porzig H, Kokubun S, Prod'hom B (1985) 1,4-Dihydropyridines as tools in the study of Ca2+ channels. Trends Neurosci 8:396–400
Reuter H, Kokubun S, Prod'hom B (1986) Properties and modulation of cardiac calcium channels. J Exp Biol 124:191–202
Reynolds IJ, Gould RJ, Snyder SH (1983) [3H]Verapamil binding sites in brain and skeletal muscle: regulation by calcium. Eur J Pharmacol 95:319–321
Reynolds IJ, Wagner JA, Snyder SH, Thayer SA, Olivera BM, Miller RJ (1986) Brain voltagesensitive calcium channel subtypes differentiated by ω-conotoxin fraction G VI A. Proc Natl Acad Sci USA 83:8804–8807
Rhodes DG, Sarmiento JG, Herbette LG (1985) Kinetics of binding of membrane-active drugs to receptor sites: diffusion limited rates for a membrane bilayer approach of 1,4-dihydropyridine calcium channel antagonists to their active site. Mol Pharmacol 27:612–623
Rios E, Brum G (1987) Involvement of dihydropyridine receptors in excitation-contraction coupling in skeletal muscle. Nature 325:717–720
Rogart RB, de Bruyn Kops A, Dzau VJ (1986) Identification of two calcium channel receptor sites for [3H]nitrendipine in mammalian cardiac and smooth muscle membrane. Proc Natl Acad Sci USA 83:7452–7456
Romey G, Lazdunski M (1982) Lipid-soluble toxins thought to be specific for Na+ channels block Ca2+ channels in neuronal cells. Nature 297:79–80
Rosenthal W, Schultz G (1988) Funktionen guaninnucleotid-bindender Proteine bei der rezeptorvermittelten Modulation spannungsabhängiger Ionenkanäle. Klin Wochenschr 66:557–564
Rosenthal W, Hescheler J, Trautwein W, Schultz G (1988a) Control of voltage-dependent Ca2+ channels by G protein-coupled receptors. FASEB J 2:2784–2790
Rosenthal W, Hescheler J, Hinsch KD, Spicher K, Trautwein W, Schultz G (1988b) Cyclic AMP-independent dual regulation of voltage-dependent Ca2+ currents by LHRH and somatostatin in a pituitary cell line. EMBO J 7:1627–1634
Sanchez-Chapula J, Josephson IR (1983) Effect of phenytoin on the sodium current in isolated rat ventricular cells. J Mol Cell Cardiol 15:515–522
Sanguinetti MC, Kass RS (1984a) Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists. Circ Res 55:336–348
Sanguinetti MC, Kass RS (1984b) Regulation of cardiac calcium channel current and contractile activity by the dihdropyridine Bay K 8644 is voltage-dependent. J Mol Cell Cardiol 16:667–670
Sanguinetti MC, Krafte DS, Kass RS (1986) Voltage-dependent modulation of Ca channel current in heart cells by Bay K 8644. J Gen Physiol 88:369–392
Sarmiento JG, Janis RA, Katz AM, Triggle DJ (1984) Comparison of high affinity binding of calcium channel blocking drugs to vascular smooth muscle and cardiac sarcolemmal membranes. Biochem Pharmacol 33:3119–3123
Sartor P, Vacher P, Mollard P, Dufy B (1988) Tamoxifen reduces calcium currents in clonal pituitary cell line. Endocrinology 123:534–540
Schettini G, Meucci O, Florio T, Grimaldi M, Landolfi E, Magri G, Yosumoto T (1988) Pertussis toxin pretreatment abolishes dihydropyridine inhibition of calcium flux in the 235-1 pituitary cell line. Biochem Biophys Res Commun 151:361–369
Scheuer T, Kass RS (1983) Phenytoin reduces calcium current in the cardiac Purkinje fiber. Circ Res 53:16–23
Schilling WP (1988) Effect of divalent cation chelation on dihydropyridine binding in isolated cardiac sarcolemmal vesicles. Biochem Biophys Acta 943:220–230
Schilling WP, Drewe JA (1986) Voltage-sensitive nitrendipine binding in an isolated cardiac sarcolemma preparation. J Biol Chem 261:2750–2758
Schmid A, Renaud JF, Lazdunski M (1985) Short term and long term effects of adrenergic effectors and cyclic AMP on nitrendipine-sensitive voltage-dependent Ca2+ channels of skeletal muscle. J Biol Chem 260:13041–13046
Scholtysik G, Rüegg P (1987) DPI 201-106. In: Scriabine A (ed) New Cardiovascular Drugs 1987. Raven Press, New York pp 173–188
Schramm M, Towart R (1988) Calcium channels as drug receptors. In: Baker PF (ed) Calcium in drug actions. Springer, Berlin Heidelberg New York, pp 89–114 (Handbook of experimental Pharmacology, vol 83)
Schramm M, Thomas G, Towart R, Franckowiak (1983) Novel dihydropyridine with positive inotropic action through activation of Ca channels. Nature 303:535–537
Schwartz A, Grupp IL, Grupp G, Williams J, Vaghy PL (1984) Effects of dihydropyridine calcium channel modulators in the heart: pharmacological and radioligand binding correlations. Biochem Biophys Res Commun 125:387–394
Schwartz LM, McCleskey EW, Almers W (1985) Dihydropyridine receptors in muscle are voltage-dependent but most are not functional calcium channels. Nature 314:747–751
Scott RH, Dolphin AC (1987) Activation of a G protein promotes agonist responses to calcium channel ligands. Nature 330:760–762
Scott RH, Dolphin AC (1988) The agonist effect of Bay K 8644 on neuronal calcium channel currents is promoted by G-protein. Neurosci Lett 89:170–175
Seeman P (1972) The membrane actions of anesthetics and tranquilizers. Pharmacol Rev 24:583–655
Sheldon RS, Cannon NJ, Duff HJ (1987) A receptor for type I antiarrhythmic drugs associated with rat cardiac sodium channels. Circ Res 61:492–497
Sheldon RS, Cannon NJ, Nies AS, Duff HJ (1988) Sterospecific interaction of tocainide with the cardiac sodium channel. Mol Pharmacol 33:327–331
Sher E, Pandiella A, Clementi F (1988) ω-Conotoxin binding and effects on calcium channel function in human neuroblastoma and rat pheochromocytoma cell lines. FEBS Lett 235:178–182
Siegl PKS, Garcia ML, King VF, Scott AL, Morgan G, Kaczorowski GJ (1988) Interactions of DPI 201-106, a novel cardiotonic agent, with cardiac calcium channels. Naunyn-Schmiedeberg's Arch Pharmacol 338:684–691
Skattebøl A, Triggle DJ (1986) 6-Hydroxydopamine treatment increases β-adrenoceptors and Ca2+ channels in rat heart. Eur J Pharmacol 127:287–289
Sladeczek F, Schmidt BH, Alonso R, Vian L, Tep A, Yasumoto T, Cory RN, Bockaert J (1988) New insights into maitotoxin action. Eur J Biochem 174:663–670
Spedding M, Gittos M, Mir AK (1987) Calcium antagonist properties of diclofurime isomers. I. Functional aspects. J Cardiovasc Pharmacol 9:461–468
Stojikovic SS, Izumi SI, Catt KJ (1988) Participation of voltage-sensitive calcium channels in pituitary hormone release. J Biol Chem 263:13054–13061
Streit J, Lux HD (1987) Voltage-dependent calcium currents in PC 12 growth cones and cells during NGF-induced cell growth. Pflügers Arch Eur J Physiol 408:634–641
Strong JA, Fox AP, Tsien RW, Kaczmarek LK (1987) Stimulation of protein kinase C recruits covert calcium channels in aplysia bag cell neurons. Nature 325:714–717
Sturek M, Hermsmeyer K (1986) Calcium and sodium channels in spontaneously contracting vascular muscle cells. Science 233:475–478
Su HD, Mazzei GJ, Vogler WR, Kuo JF (1985) Effect of tamoxifen, a nonsteroidal antioestrogen, on phospholipid calcium-dependent protein kinase and phosphorylation of its endogenous substrate proteins from the rat brain and ovary. Biochem Pharmacol 34:3649–3653
Sumimoto K, Hirata M, Kuriyama H (1988) Characterization of [3H]nifedipine binding to intact vascular smooth muscle cells. Am J Physiol 254:C45–C52
Swandulla D, Armstrong CM (1988) Fast-deactivating calcium channels in chick sensory neurons. J Gen Physiol 92:197–218
Taft WC, DeLorenzo RJ (1984) Micromolar-affinity benzodiazepine receptors regulate voltage-sensitive calcium channels in nerve terminal preparations. Proc Natl Acad Sci USA 81:3118–3122
Takahashi M, Tsukui H, Hatanaka H (1985) Neuronal differentiation of Ca2+ channel by nerve growth factor. Brain Res 341:381–384
Tan KN, Tashijan AH Jr (1984a) Voltage-dependent calcium channels in pituitary cells in culture. I. Characterization by 45Ca2+ fluxes. J Biol Chem 259:418–426
Tan KN, Tashijan AH Jr (1984b) Voltage-dependent calcium channels in pituitary cells in culture. II. Participation in thyrotropin-releasing hormone action. J Biol Chem 259:427–434
Tanabe T, Takeshima H, Mikami A, Flockerzi V, Takahashi H, Kangawa K, Kojima M, Matsuo H, Hirose T, Numa S (1987) Primary structure of the receptor for calcium channel blockers from skeletal muscle. Nature 328:313–318
Tang CM, Presser F, Morad M (1988) Amiloride selectively blocks the low threshold calcium channel. Science 240:213–215
Thayer SA, Hirning LD, Miller RJ (1987) The distribution of multiple types of Ca2+ channels in rat sympathetic neurons in vitro. Mol Pharmacol 32:579–586
Thomas G, Gross R, Schramm M (1984) Calcium channel modulation: ability to inhibit or promote calcium influx resides in the same dihydropyridine molecule. J Cardiovasc Pharmacol 6:1170–1176
Toll L (1982) Calcium antagonists. High-affinity binding and inhibition of calcium transport in a clonal cell line. J Biol Chem 257:13189–13192
Triggle DJ, Janis RA (1987) Calcium channel ligands. Annu Rev Pharmacol Toxicol 27:347–370
Tsien RW (1987) Calcium currents in heart cells and neurons. In: Kaczmarek LK, Levitan IB (eds) Neuromodulation. The biochemical control of neuronal excitability. Oxford University Press, Oxford, pp 206–242
Tsien RW, Hess P, McCleskey EW, Rosenberg RL (1987) Calcium channels: mechanisms of selectivity, permeation and block. Annu Rev Biophys Biophys Chem 16:265–290
Tsien RW, Lipscombe D, Madison DV, Bley RK, Fox AP (1988) Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci 11:431–438
Tsunoo A, Yoshii M, Narahashi T (1985) Differential block of two calcium channels in neuroblastoma cells. Biophys J 47:433a
Tsunoo A, Yoshii M, Narahashi T (1986) Block of calcium channels by enkephalin and somatostatin in neuroblastoma-glioma hybrid NG-108-15 cells. Proc Natl Acad Sci USA 83:9832–9836
Twombly DA, Yoshii M, Narahashi T (1988) Mechanism of calcium channel block by phenytoin. J Pharmacol Exp Ther 246:189–195
Tytgat J, Vereeke J, Carmeliet E (1988) Differential effects of verapamil and flunarizine on cardial L-type and T-type Ca channels. Naunyn Schmiedeberg's Arch Pharmacol 337:690–692
Uehara A, Hume JR (1985) Interactions of organic calcium channel antagonists with calcium channels in single frog atrial cells. J Gen Physiol 85:621–648
Vaghy PL, Grupp IL, Grupp G, Schwartz A (1984a) Effects of Bay K 8644, a dihydropyridine analog on [3H]nitrendipine binding to canine cardiac sarcolemma and the relationship to a positive inotropic effect. Circ Res 55:549–553
Vaghy PL, Grupp IL, Grupp G, Balwierczak JL, Williams JS, Schwartz A (1984b) Correlation of nitrendipine and Bay K 8644 binding to isolated canine heart sarcolemma with their pharmacological effects on the canine heart. Eur J Pharmacol 102:373–374
Van Skiver, Spires S, Cohen CJ (1988) Block of T-type Ca channels in guinea pig atrial cells by cinnarizine. Biophys J 53:233a
Vilven J, Leung AT, Imagawa T, Sharp AH, Campbell KP, Coronado R (1988) Interaction of calcium channels of skeletal muscle with monoclonal antibodies specific for its dihydropyridine receptor. Biophys J 53:556a (abstract)
Wagner JA, Snowman AM, Biswas A, Olivera BM, Snyder SH (1988) ω-Conotoxin G VI A binding to a high-affinity receptor in brain: characterization, calcium sensitivity and solubilization. J Neurosci 8:3354–3359
Walker MW, Ewald DA, Perney TM, Müller RJ (1988) Neuropeptide Y modulates neurotransmitter release and Ca2+ currents in rat sensory neurones. J Neurosci 8:2438–2446
Wanke E, Ferroni A, Malgaroli A, Ambrosini A, Pozzan T, Meldolesi J (1987) Activation of a muscarinic receptor selectively inhibits a rapidly inactivated Ca2+ current in rat sympathetic neurons. Proc Natl Acad Sci USA 84:4313–4317
Werz MA, MacDonald RL (1985) Dynorphin and neoendorphin peptides decrease dorsal root ganglion neuron calcium-dependent action potential duration. J Pharmacol Exp Ther 234:49–56
Williams JS, Grupp IL, Grupp G, Vaghy PL, Dumont L, Schwartz A, Yatani A, Hamilton S, Brown AM (1985) Profile of the oppositely acting enantiomers of the dihydropyridine 202–791 in cardiac preparations: receptor binding, electrophysiological and pharmacological studies. Biochem Biophys Res Commun 131:13–21
Willow M (1986) Pharmacology of diphenylhydantoin and carbamazepine action on voltage-sensitive sodium channels. Trends Neurosci 9:147–149
Willow M, Gonoi T, Catterall WA (1985) Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells. Mol Pharmacol 27:549–558
Wright JM, Collier B (1977) The effects of neomycin upon transmitter release and action. J Pharmacol Exp Ther 200:576–587
Wu CH, Narahashi T (1988) Mechanism of action of novel marine neurotoxins on ion channels. Annu Rev Pharmacol Toxicol 28:141–162
Yamashita N, Matsunaga H, Shibuya N, Teramoto A, Takakura K, Ogata E (1988) Two types of calcium channels and hormone release in human pituitary tumor cells. Am J Physiol 255:E137–E145
Yatani A, Brown AM (1985) The calcium channel blocker nitrendipine blocks sodium channels in neonatal rat cardiac myocytes. Circ Res 56:868–875
Yatani A, Brown AM, Schwartz A (1986a) Bepridil block of cardiac calcium and sodium channels. J Pharmacol Exp Ther 237:9–17
Yatani A, Hamilton SL, Brown AM (1986b) Diphenylhydantoin blocks cardiac calcium channels and binds to the dihydropyridine receptor. Circ Res 59:356–361
Yatani A, Codina J, Imoto Y, Reeves JP, Birnbaumer L, Brown AM (1987) A G protein directly regulates mammalian cardiac calcium channels. Science 238:1288–1292
Yatani A, Kunze DL, Brown AM (1988a) Effects of dihydropyridine calcium channel modulators on cardiac sodium channels. Am J Physiol 254:H140–H147
Yatani A, Imoto Y, Codina J, Hamilton SL, Brown AM, Birnbaumer L (1988b) The stimulatory G protein of adenylyl cyclase Gs also stimulates dihydropyridine-sensitive Ca2+ channels. Evidence for direct regulation independent of phosphorylation by cAMP-dependent protein kinase or stimulation by a dihydropyridine agonist. J Biol Chem 263:9887–9895
Yeh JZ (1980) Blockage of sodium channels by stereoisomers of local anesthetics. In: Fink BR (ed) Molecular mechanisms of anaesthesia. Raven, New York, pp 35–44 (Progress in anesthesiology, vol 2)
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag
About this chapter
Cite this chapter
Porzig, H. (1990). Pharmacological modulation of voltage-dependent calcium channels in intact cells. In: Reviews of Physiology, Biochemistry and Pharmacology, Volume 114. Reviews of Physiology, Biochemistry and Pharmacology, vol 114. Springer, Berlin, Heidelberg. https://doi.org/10.1007/BFb0031020
Download citation
DOI: https://doi.org/10.1007/BFb0031020
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-51693-4
Online ISBN: 978-3-540-46754-0
eBook Packages: Springer Book Archive